Page 58 - Read Online
P. 58

Diab et al. J Cancer Metastasis Treat 2022;8:42                    Journal of Cancer
               DOI: 10.20517/2394-4722.2022.60
                                                                       Metastasis and Treatment




               Review                                                                        Open Access



               The heterogeneity of CAFs and immune cell
               populations in the tumor microenvironment of

               pancreatic adenocarcinoma

                        1
               Maria Diab , Bassel F. El-Rayes 2
               1
                Department of Hematology and Oncology, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA.
               2
                Division of Hematology and Oncology, University of Alabama, Birmingham, AL 35294 USA.
               Correspondence to: Dr. Maria Diab, Department of Hematology and Oncology, Winship Cancer Institute of Emory University,
               1365 Clifton Rd NE Atlanta, Atlanta, GA 30322, USA. E-mail: maria.diab@emory.edu

               How to cite this article: Diab M, El-Rayes BF. The heterogeneity of CAFs and immune cell populations in the tumor
               microenvironment of pancreatic adenocarcinoma. J Cancer Metastasis Treat 2022;8:42. https://dx.doi.org/10.20517/2394-
               4722.2022.60
               Received: 24 May 2022  First Decision: 8 Jul 2022  Revised: 29 Jul 2022  Accepted: 19 Sep 2022  Published: 27 Sep 2022

               Academic Editors: Antonio Facciorusso, Yogesh Vashist  Copy Editor: Fangling Lan  Production Editor: Fangling Lan

               Abstract
               Over the past decade, researchers have identified and characterized the diverse cell populations within the tumor
               microenvironment of pancreatic cancer. The interplay between these cells in the TME either promotes or inhibits
               the malignant behavior of pancreatic cancer cells. Cancer-associated fibroblasts, previously thought to be one main
               subset, can now be broadly subclassified into three main types: inflammatory, myofibroblastic, and antigen-
               presenting, with the former and the latter two exerting pro-tumoral and anti-tumoral functions, respectively.
               Myeloid cells include myeloid-derived suppressor cells and tumor-associated macrophages. Myeloid-derived
               suppressor cells can be further divided into polymorphonuclear and monocytic and exhibit pro-tumoral activities.
               Tumor-associated macrophages exhibit M1 (anti-tumoral) or M2 (pro-tumoral) phenotypes, which are present in a
               dynamic fashion between the two phenotypes. Other constituents of the immune make-up of the tumor
               microenvironment include T and B cells and less described subsets which include natural killer cells, γδ T cells, and
               group 2 innate lymphoid cells. This review provides an overview of the studies that lead to the discovery of those
               cellular populations and highlights the recent efforts to utilize them as therapeutic targets in pancreatic cancer.

               Keywords: Tumor microenvironment, pancreatic cancer, cancer-associated fibroblast, myeloid cells, T cells









                           © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing,
                           adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as
               long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
               indicate if changes were made.

                                                                                           www.jcmtjournal.com
   53   54   55   56   57   58   59   60   61   62   63